Deciphera Pharmaceuticals, Inc. (DCPH): $47.00

-0.23 (-0.49%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add DCPH to Watchlist
Sign Up

Industry: Biotech


Ranked

of 494

in industry

Deciphera Pharmaceuticals Inc (DCPH) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering DCPH.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
11 $84 $70 $75.73 $45.96 64.77%

The Trend in the Analyst Price Target


Over the past 133 days, DCPH's average price target has gone down $0.82.

DCPH reports an average of 49.9% for its upside potential over the past 330 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-05-15 12 91 55 72.50 51.74 40.12%
2020-07-11 12 91 55 72.50 54.24 33.67%
2020-07-13 11 91 55 73.64 52.23 40.99%
2020-07-21 10 91 55 74.80 49.89 49.93%
2020-08-05 10 91 54 74.70 48.40 54.34%
2020-09-14 11 91 52 73.00 50.06 45.83%
2020-11-11 11 91 64 76.45 65.15 17.34%
2020-11-28 11 91 65 76.55 62.35 22.77%
2020-12-07 12 91 65 76.42 55.86 36.81%
2020-12-10 12 91 65 76.42 55.91 36.68%
2020-12-19 12 91 65 76.42 54.86 39.3%
2020-12-26 12 91 65 76.42 58.88 29.79%
2021-01-02 12 91 65 76.42 57.07 33.91%
2021-01-09 12 91 65 76.42 56.24 35.88%
2021-01-16 12 91 65 76.42 50.07 52.63%
2021-01-23 12 91 65 76.42 46.76 63.43%
2021-01-30 12 91 65 76.42 44.20 72.9%
2021-02-06 12 91 65 76.42 51.36 48.79%
2021-02-13 11 84 70 75.00 48.91 53.34%
2021-02-20 11 84 70 75.00 44.46 68.69%
2021-02-27 11 84 70 75.00 43.78 71.31%
2021-03-06 11 84 70 75.00 42.79 75.27%
2021-03-13 11 84 70 75.00 43.12 73.93%
2021-03-20 11 84 70 75.00 46.21 62.3%
2021-04-03 11 84 70 75.73 46.03 64.52%
2021-04-10 11 84 70 75.73 43.81 72.86%

DCPH Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.38 4 7 1 0 0 12

The Trend in the Broker Recommendations


list("500 - Internal server error")

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for DCPH as an investment opportunity.

  • DCPH has a higher upside potential (average analyst target price relative to current price) than 92.3% of stocks in the mid market cap category.
  • DCPH has a greater number of analysts covering the stock than 87.55% of Pharmaceutical Products stocks.
  • The average analyst price target of DCPH is greater than 87.26% of Pharmaceutical Products stocks.
  • DCPH has a less variance in analysts' estimates than 77.45% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, IOVA, ARVN and REPL are the three stocks most similar to Deciphera Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding DCPH using the data that counts. Try POWR Ratings for free.



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7676 seconds.